Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse
- PMID: 11441005
- DOI: 10.1074/jbc.M102780200
Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse
Abstract
Hyperphosphorylated tau is the major component of paired helical filaments in neurofibrillary tangles found in Alzheimer's disease (AD) brain. Starvation of adult mice induces tau hyperphosphorylation at many paired helical filaments sites and with a similar regional selectivity as those in AD, suggesting that a common mechanism may be mobilized. Here we investigated the mechanism of starvation-induced tau hyperphosphorylation in terms of tau kinases and Ser/Thr protein phosphatases (PP), and the results were compared with those reported in AD brain. During starvation, tau hyperphosphorylation at specific epitopes was accompanied by decreases in tau protein kinase I/glycogen synthase kinase 3 beta (TPKI/GSK3 beta), cyclin-dependent kinase 5 (cdk5), and PP2A activities toward tau. These results demonstrate that the activation of TPKI/GSK3 beta and cdk5 is not necessary to obtain hyperphosphorylated tau in vivo, and indicate that inhibition of PP2A is likely the dominant factor in inducing tau hyperphosphorylation in the starved mouse, overriding the inhibition of key tau kinases such as TPKI/GSK3 beta and cdk5. Furthermore, these data give strong support to the hypothesis that PP2A is important for the regulation of tau phosphorylation in the adult brain, and provide in vivo evidence in support of a central role of PP2A in tau hyperphosphorylation in AD.
Similar articles
-
Role of protein phosphatase-2A and -1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.FEBS Lett. 2000 Nov 17;485(1):87-93. doi: 10.1016/s0014-5793(00)02203-1. FEBS Lett. 2000. PMID: 11086171
-
Physiology and pathology of tau protein kinases in relation to Alzheimer's disease.J Biochem. 1997 Feb;121(2):179-88. J Biochem. 1997. PMID: 9089387 Review.
-
Inhibition of glycogen synthase kinase-3beta downregulates total tau proteins in cultured neurons and its reversal by the blockade of protein phosphatase-2A.Brain Res. 2009 Feb 3;1252:66-75. doi: 10.1016/j.brainres.2008.11.057. Epub 2008 Nov 30. Brain Res. 2009. PMID: 19071093
-
Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?J Biol Chem. 2001 Jan 5;276(1):251-60. doi: 10.1074/jbc.M002466200. J Biol Chem. 2001. PMID: 11013232
-
Possible role of tau protein kinases in pathogenesis of Alzheimer's disease.Neurobiol Aging. 1998 Jan-Feb;19(1 Suppl):S93-8. doi: 10.1016/s0197-4580(98)00025-6. Neurobiol Aging. 1998. PMID: 9562476 Review.
Cited by
-
Glucose deprivation increases tau phosphorylation via P38 mitogen-activated protein kinase.Aging Cell. 2015 Dec;14(6):1067-74. doi: 10.1111/acel.12381. Epub 2015 Jul 29. Aging Cell. 2015. PMID: 26219917 Free PMC article.
-
Cyclin-Dependent kinase 5 targeting prevents β-Amyloid aggregation involving glycogen synthase kinase 3β and phosphatases.J Neurosci Res. 2015 Aug;93(8):1258-66. doi: 10.1002/jnr.23576. Epub 2015 Feb 24. J Neurosci Res. 2015. PMID: 25711385 Free PMC article.
-
Neurobiochemical, Peptidomic, and Bioinformatic Approaches to Characterize Tauopathy Peptidome Biomarker Candidates in Experimental Mouse Model of Traumatic Brain Injury.Mol Neurobiol. 2023 Apr;60(4):2295-2319. doi: 10.1007/s12035-022-03165-y. Epub 2023 Jan 13. Mol Neurobiol. 2023. PMID: 36635478
-
Cdk5 as a drug target for the treatment of Alzheimer's disease.J Mol Neurosci. 2002 Dec;19(3):267-73. doi: 10.1385/JMN:19:3:267. J Mol Neurosci. 2002. PMID: 12540052 Review.
-
Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.Am J Pathol. 2005 Feb;166(2):521-31. doi: 10.1016/S0002-9440(10)62274-2. Am J Pathol. 2005. PMID: 15681835 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous